Jun Kong

622 total citations
48 papers, 378 citations indexed

About

Jun Kong is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Jun Kong has authored 48 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 11 papers in Immunology and 9 papers in Oncology. Recurrent topics in Jun Kong's work include Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (13 papers) and Immune Cell Function and Interaction (9 papers). Jun Kong is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (13 papers) and Immune Cell Function and Interaction (9 papers). Jun Kong collaborates with scholars based in China, Malaysia and Brazil. Jun Kong's co-authors include Xiao‐Jun Huang, Lan‐Ping Xu, Yu Wang, Kai‐Yan Liu, Chen‐Hua Yan, Xiaohui Zhang, Yuqian Sun, Chengli Liu, Zujun Xie and Yong Zheng and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Jun Kong

38 papers receiving 371 citations

Peers

Jun Kong
Chiaki Kato Japan
Irene García‐Cadenas Spain
Pınar Ataca Atilla Türkiye
Albert Esquirol Spain
Yuichiro Nawa Japan
Johan Törlén Sweden
Amin T. Turki Germany
Vincent T. Ho United States
Yasuhiko Shibasaki Japan
Silvia Maria Trisolini Italy
Chiaki Kato Japan
Jun Kong
Citations per year, relative to Jun Kong Jun Kong (= 1×) peers Chiaki Kato

Countries citing papers authored by Jun Kong

Since Specialization
Citations

This map shows the geographic impact of Jun Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Kong more than expected).

Fields of papers citing papers by Jun Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Kong. The network helps show where Jun Kong may publish in the future.

Co-authorship network of co-authors of Jun Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Kong. A scholar is included among the top collaborators of Jun Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Kong. Jun Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaomei, Ning Na, Haibin Hao, et al.. (2025). Head and neck cancer organoids: a panoramic perspective from basic construction to clinical translation. Stem Cell Research & Therapy. 16(1). 534–534.
2.
3.
4.
Kong, Jun, et al.. (2025). Treatment of transplantation-associated thrombotic microangiopathy with iptacopan: two cases report. Annals of Hematology. 104(10). 5537–5541.
5.
6.
Wu, Ning, Chen‐Hua Yan, Jun Kong, et al.. (2025). Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative Study. Transplantation and Cellular Therapy. 32(3). 302.e1–302.e10.
7.
Li, Shasha, Jun Kong, Qi Zhang, et al.. (2025). Therapeutic potential of voltage-dependent potassium channel subtype 1.3 blockade in alleviating macrophage-related renal inflammation and fibrogenesis. Cell Death Discovery. 11(1). 218–218. 1 indexed citations
8.
Guo, Huidong, Liping Guo, Bixia Wang, et al.. (2024). Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation. Advanced Science. 11(39). e2400544–e2400544. 9 indexed citations
9.
10.
Kong, Jun, et al.. (2024). Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges. Frontiers in Immunology. 15. 1384039–1384039. 14 indexed citations
11.
Fu, Huaying, Yuqian Sun, Xiao‐Dong Mo, et al.. (2024). [Clinical features and risk factors for invasive fungal sinusitis after allogeneic hematopoietic stem cell transplantation].. PubMed. 45(1). 22–27. 1 indexed citations
12.
Fu, Hai‐Xia, Meng Lv, Huixin Liu, et al.. (2023). Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation. Bone Marrow Transplantation. 58(12). 1368–1376. 1 indexed citations
13.
Gao, Mengge, Jun Kong, Yuqian Sun, et al.. (2023). G-CSF Induces MAIT Cells to Exert Anti-Intestinal Gvhd Effects Dependent on CXCR6 Mediated Chemotaxis. Blood. 142(Supplement 1). 2048–2048. 1 indexed citations
14.
Huang, Junbin, Guanhua Hu, Lu Bai, et al.. (2023). Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study. Frontiers in Oncology. 13. 1116205–1116205. 2 indexed citations
15.
Hu, Jia, Can Zhao, Yan Luo, et al.. (2023). Real-time corneal thickness changes during phacoemulsification cataract surgery. Graefe s Archive for Clinical and Experimental Ophthalmology. 261(6). 1609–1618. 1 indexed citations
16.
17.
Jiang, Hao, Xiaohong Liu, Jun Kong, et al.. (2021). Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia. Leukemia & lymphoma. 62(12). 2949–2956. 14 indexed citations
18.
Yan, Chen‐Hua, Yu Wang, Xiao‐Dong Mo, et al.. (2020). Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation. Bone Marrow Transplantation. 55(6). 1147–1160. 17 indexed citations
19.
Liu, Jun, Jun Kong, Ying‐Jun Chang, et al.. (2015). Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality. Clinical Microbiology and Infection. 21(12). 1121.e9–1121.e15. 69 indexed citations
20.
Mo, Xiao‐Dong, Jun Kong, Ting Zhao, et al.. (2014). Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical Outcomes. Biology of Blood and Marrow Transplantation. 20(12). 2023–2028. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiaki Kato Breakdown of academic impact, for papers by Irene García‐Cadenas Breakdown of academic impact, for papers by Pınar Ataca Atilla Breakdown of academic impact, for papers by Albert Esquirol Breakdown of academic impact, for papers by Yuichiro Nawa Breakdown of academic impact, for papers by Johan Törlén Breakdown of academic impact, for papers by Amin T. Turki Breakdown of academic impact, for papers by Vincent T. Ho Breakdown of academic impact, for papers by Yasuhiko Shibasaki Breakdown of academic impact, for papers by Silvia Maria Trisolini
Rankless by CCL
2026